Endophthalmitis After Dexamethasone Implant

20260 citationsJournal Articlebronze Open Access

Authors

Maryam Eghtedari · The Royal Victorian Eye & Ear Hospital

Zelia K. Chiu · The Royal Victorian Eye & Ear Hospital

Fatemeh Shams · The Royal Victorian Eye & Ear Hospital

Penelope J. Allen · The University of Melbourne

Rosie C. H. Dawkins · The University of Melbourne

Abstract

The rate of dexamethasone implant-related endophthalmitis is 0.16% which is higher than other intravitreal injections reported in the literature, with considerably poor visual outcomes. The vitreous diagnostic samples are culture-positive in 87% of cases (13/15), with 46.7% (7/15) isolating Staphylococcus epidermidis.

Topics & Keywords

Ocular Infections and Treatments Retinal Diseases and Treatments Ocular Diseases and Behçet’s Syndrome

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical and Experimental Ophthalmology

DOI: 10.1111/ceo.70066

Field-Weighted Citation Impact: 0.00